$24.77
In chiusura: Oct 28 EDT
$24.82
0.050.20%
Pre-mercato: 7:26 AM EDT
Pfizer segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Pfizer utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
PFE | Pfizer | $1.06 | $0.66 | — | — | $17.70B | $16.67B | — | — | 11/04/2025 | |
PFE | Pfizer | $0.60 | $0.58 | $0.78 | 34.48% | $13.28B | $13.63B | $14.70B | 7.85% | 08/05/2025 | |
PFE | Pfizer | $0.82 | $0.67 | $0.92 | 37.31% | $14.88B | $13.95B | $13.71B | -1.68% | 04/29/2025 | |
PFE | Pfizer | $0.10 | $0.46 | $0.63 | 36.96% | $14.25B | $17.26B | $17.76B | 2.91% | 02/04/2025 | |
PFE | Pfizer | -$0.17 | $0.62 | $1.06 | 70.97% | $13.49B | $14.95B | $17.70B | 18.41% | 10/29/2024 | |
PFE | Pfizer | $0.67 | $0.46 | $0.60 | 30.43% | $13.01B | $13.02B | $13.28B | 2.02% | 07/30/2024 | |
PFE | Pfizer | $1.23 | $0.52 | $0.82 | 57.69% | $18.28B | $14.01B | $14.88B | 6.20% | 05/01/2024 | |
PFE | Pfizer | $1.14 | -$0.22 | $0.10 | 145.45% | $24.29B | $14.21B | $14.25B | 0.27% | 01/30/2024 | |
PFE | Pfizer | $1.78 | -$0.32 | -$0.17 | 46.88% | $22.64B | $12.72B | $13.23B | 4.03% | 10/31/2023 | |
PFE | Pfizer | $2.04 | $0.57 | $0.67 | 17.54% | $27.74B | $13.17B | $12.73B | -3.31% | 08/01/2023 | |
PFE | Pfizer | $1.62 | $0.98 | $1.23 | 25.51% | $25.66B | $16.59B | $18.28B | 10.20% | 05/02/2023 | |
PFE | Pfizer | $1.08 | $1.05 | $1.14 | 8.57% | $23.84B | $24.32B | $24.29B | -0.12% | 01/31/2023 | |
PFE | Pfizer | $1.34 | $1.47 | $1.78 | 21.09% | $24.09B | $21.37B | $22.64B | 5.93% | 11/01/2022 | |
PFE | Pfizer | $1.07 | $1.80 | $2.04 | 13.33% | $18.98B | $25.98B | $27.74B | 6.78% | 07/28/2022 | |
PFE | Pfizer | $0.93 | $1.50 | $1.62 | 8.00% | $14.58B | $23.95B | $25.66B | 7.14% | 05/03/2022 | |
PFE | Pfizer | $0.42 | $0.87 | $1.08 | 24.14% | $11.68B | $24.20B | $23.84B | -1.50% | 02/08/2022 | |
PFE | Pfizer | $0.72 | $1.09 | $1.34 | 22.94% | $12.13B | $22.71B | $24.09B | 6.09% | 11/02/2021 | |
PFE | Pfizer | $0.78 | $0.96 | $1.07 | 11.46% | $11.80B | $18.45B | $18.98B | 2.86% | 07/28/2021 | |
PFE | Pfizer | $0.80 | $0.78 | $0.93 | 19.23% | $12.03B | $13.60B | $14.58B | 7.22% | 05/04/2021 | |
PFE | Pfizer | $0.55 | $0.48 | $0.42 | -12.50% | $12.69B | $11.43B | $11.68B | 2.22% | 02/02/2021 |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-05 | $0.78 | $0.58 | 34.5 % |
| Q1 | 2025-04-29 | $0.92 | $0.67 | 37.3 % |
| Q4 | 2025-02-04 | $0.63 | $0.46 | 37.0 % |
| Q3 | 2024-10-29 | $1.06 | $0.62 | 71.0 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-05 | $14.70B | $13.63B | 7.85 % |
| Q1 | 2025-04-29 | $13.72B | $13.95B | -1.68 % |
| Q4 | 2025-02-04 | $17.76B | $17.26B | 2.91 % |
| Q3 | 2024-10-29 | $17.70B | $14.95B | 18.4 % |
Si prevede che Pfizer (PFE) fornisca risultati il novembre 4, 2025. Gli ultimi risultati sono stati pubblicati il agosto 5, 2025 per il Q2.
L'EPS effettivo era $0.78, che superato la stima di $0.58.
Le entrate effettive sono state $14.7B, che superato la stima di $13.6B.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.